Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Celgene claims PDE/TNF/NFkappaB inhibitors

Sep. 5, 1997

Summary of azelnidipine preclinical data

Sep. 5, 1997

Fullerene derivative with vasorelaxant effects described by Japanese academics

Sep. 5, 1997

Spotlight on adenosine A1 receptor agonists

Sep. 4, 1997

DANAMI trial results presented

Sep. 4, 1997

Role of vitamin C in cardiovascular diseases investigated

Sep. 4, 1997

Lipoprotein(a): new insights into the process of atherosclerosis

Sep. 4, 1997

Large, long-term trial evaluates association between heart rate and mortality

Sep. 4, 1997

Alcohol abuse and atherosclerosis

Sep. 3, 1997

VEGF prevents in-stent restenosis in rabbits

Sep. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...